This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXMPEE5B1AF_M.jpg
Morgan Stanley cut its price targets on Visa (NYSE:V) to $282 from $291 and on Mastercard Inc (NYSE:MA) to $441 from $457, based on FX headwinds due to the large international exposure. The analysts reiterated their Overweight Rating on both companies.
BofA Securities lowered its price target on Amazon (NASDAQ:AMZN) to $157 from $170, while maintaining a Buy rating. The analysts lowered their forward estimates, reflecting higher macroeconomic uncertainty as well as U.S. dollar appreciation since mid-August.
Deutsche Bank lowered the price target on Rite Aid Corporation (NYSE:RAD) to $3.00 from $4.00, while maintaining a Sell rating. This was followed by the company’s Q2 earnings announcement, which showed the company’s core pharmacy business continues to erode.
Goldman Sachs raised the price target on Regeneron Pharma (NASDAQ:REGN) to $970.00 from $796.00, while reiterating its Buy rating.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
